SA
Samreen Afsar
About Samreen Afsar
Data last updated:
Samreen Afsar has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Vyonics Healthcare India Private Limited and Visilens Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Vyonics Healthcare India Private Limited at ₹7.39 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jul 2016 | 2016 | ₹7.39 Cr (FY 2025) | Active | |
| Director | 11 Dec 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samreen Afsar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samreen Afsar
Samreen Afsar has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Vyonics Healthcare India Private Limited and Visilens Pharmaceuticals Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Vyonics Healthcare India Private Limited at ₹7.39 Cr (FY 2025).
Samreen Afsar is associated with 2 companies as Director, including Vyonics Healthcare India Private Limited (₹7.39 Cr), Visilens Pharmaceuticals Private Limited.
Samreen Afsar has expertise in Healthcare, General Business.
Samreen Afsar has 10 years in corporate governance.
By reported revenue, the largest current company of Samreen Afsar is Vyonics Healthcare India Private Limited, with revenue of ₹7.39 Cr (FY 2025).
Samreen Afsar currently holds positions at 2 companies: Vyonics Healthcare India Private Limited (₹7.39 Cr), Visilens Pharmaceuticals Private Limited.